Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2014

Date: October 31, 2014
Pages: 182
Price:
US$ 2,500.00 US$ 1,875.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M0E4914F431EN
Leaflet:

Download PDF Leaflet

Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2014' provides data on the Multiple Myeloma (Kahler’s Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Multiple Myeloma (Kahler’s Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Multiple Myeloma (Kahler’s Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Copanies
Introduction
Multiple Myeloma (Kahler's Disease)
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Multiple Myeloma (Kahler's Disease) to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Multiple Myeloma (Kahler's Disease) to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Multiple Myeloma (Kahler's Disease)
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Multiple Myeloma (Kahler's Disease)
Oct 01, 2014: Innate Pharma Announces Initiation of a Phase I clinical trial of Lirilumab in combination with elotuzumab
Sep 25, 2014: Novel Compound Prevents Metastasis of Multiple Myeloma in Mouse Studies
Sep 04, 2014: Cleave Biosciences Initiates Phase 1 Clinical Trial of CB-5083 in Patients with Multiple Myeloma
Aug 25, 2014: Patrys Releases Details of PAT-SM6 & Carfilzomib Clinical Trial
Aug 11, 2014: Genmab Announces New Phase III Study of Daratumumab in Front Line Multiple Myeloma
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Takeda Pharmaceutical Company Limited
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Novartis AG
Clinical Trial Overview of Novartis AG
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Sanofi
Clinical Trial Overview of Sanofi
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Clinical Trial Overview of Top Institutes / Government
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center
University of Arkansas
Clinical Trial Overview of University of Arkansas
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
Washington University School of Medicine
Clinical Trial Overview of Washington University School of Medicine
Barbara Ann Karmanos Cancer Institute
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

LIST OF TABLES

Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials by Region, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, North America, Top Countries, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014
Proportion of Multiple Myeloma (Kahler's Disease) to Oncology Clinical Trials, G7 Countries (%), 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Multiple Myeloma (Kahler's Disease) to Oncology Clinical Trials, E7 Countries (%), 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials by Phase, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Suspended Clinical Trials, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Withdrawn Clinical Trials, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Terminated Clinical Trials, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Multiple Myeloma (Kahler's Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Arkansas, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2014

LIST OF FIGURES

Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials by Region (%), 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014
Proportion of Multiple Myeloma (Kahler's Disease) to Oncology Clinical Trials, G7 Countries (%), 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Multiple Myeloma (Kahler's Disease) to Oncology Clinical Trials, E7 Countries (%), 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Multiple Myeloma (Kahler's Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
GlobalData Methodology
Skip to top


Ask Your Question

Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: